Valuation: Manhattan Scientifics, Inc.

Capitalization 447K 426K 395K 351K 634K 37.97M 702K 4.91M 1.81M 15.59M 1.68M 1.64M 68.04M P/E ratio 2022
-1.64x
P/E ratio 2023 -1.25x
Enterprise value 440K 419K 388K 346K 624K 37.38M 691K 4.84M 1.79M 15.35M 1.65M 1.62M 66.97M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
84.55%
Yield 2022 *
-
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
1 day+6.67%
Current month-11.11%
1 month-27.27%
3 months-38.46%
6 months-50.00%
Current year-69.23%
More quotes
1 week
0.00
Extreme 0.0007
0.00
1 month
0.00
Extreme 0.0007
0.00
Current year
0.00
Extreme 0.0004
0.01
1 year
0.00
Extreme 0.0004
0.01
3 years
0.00
Extreme 0.0004
0.02
5 years
0.00
Extreme 0.0004
0.05
10 years
0.00
Extreme 0.0004
0.12
More quotes
Director TitleAgeSince
Chief Executive Officer 72 2007-10-31
President 87 1997-12-31
Manager TitleAgeSince
Chairman 87 -
Chairman 72 2007-10-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+6.67%0.00%-76.47%-96.02%447K
0.00%-1.90%+3.00%+8.04%381M
+0.67%0.00%+13.21%+5.63%350M
-.--%-.--%-.--%+25.00%139M
-0.93%0.00%-22.06% - 135M
-1.72%-4.91%+26.42%-71.58%86.53M
-1.07%-5.13%+90.72%-3.65%62.68M
Average +0.52%-1.71%+4.97%-22.09% 164.98M
Weighted average by Cap. -0.09%-2.02%+9.29%+2.01%
See all sector performances

Financials

2022 2023
Net sales 0.05 0.05 0.04 0.04 0.07 4.24 0.08 0.55 0.2 1.74 0.19 0.18 7.6 -
Net income -2.73M -2.6M -2.41M -2.14M -3.87M -232M -4.28M -29.98M -11.07M -95.13M -10.25M -10.03M -415M -1.16M -1.11M -1.03M -914K -1.65M -98.86M -1.83M -12.8M -4.72M -40.6M -4.37M -4.28M -177M
Net Debt -65K -61.87K -57.33K -50.99K -92.05K -5.52M -102K -714K -264K -2.26M -244K -239K -9.88M -7K -6.66K -6.17K -5.49K -9.91K -594K -10.99K -76.88K -28.38K -244K -26.28K -25.71K -1.06M
More financial data * Estimated data
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
More about the company
Date Price Change Volume
24-12-09 0.000800 $ +6.67% 746,688
24-12-06 0.000750 $ -6.25% 15,999
24-12-05 0.000800 $ 0.00% 38,332
24-12-04 0.000800 $ 0.00% 1,680,660
24-12-03 0.000800 $ 0.00% 101,825

Delayed Quote OTC Markets, December 09, 2024 at 03:29 pm EST

More quotes